Jaguar Health executed a debt-for-equity exchange with Streeterville Capital, issuing 547,898 new common shares to reduce a promissory note by over $5 million. This transaction immediately diluted existing shareholders by 42.7%, leading to a sharp decline in the stock price due to concerns over increased share supply.
Jaguar Health (JAGX) converted a portion of its debt with Streeterville Capital into equity, issuing 547,898 new shares. This move, while reducing the company's debt burden by over $5 million, resulted in an immediate 42.7% increase in the outstanding share count. The market reacted negatively, causing the stock to slide significantly, as the influx of new shares creates substantial dilution for existing shareholders and a potential supply overhang as the lender can sell these shares in the open market. This highlights Jaguar's ongoing liquidity challenges and its strategy to preserve cash, but at the cost of shareholder value in the short term.